Evidence map›Paper›PMID 37129527›Full record

ArticleInfection and immunity2023

The Brucella abortus Type IV Effector BspA Inhibits MARCH6-Dependent ERAD To Promote Intracellular Growth.

Stanimir Kambarev, Elizabeth Borghesan, Cheryl N Miller, Sebenzile Myeni, Jean Celli

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Review
  3. Article
  4. ThemicroLife · 2025
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Stanimir KambarevPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.
Elizabeth BorghesanPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.
Cheryl N MillerPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.ORCID 0000-0003-3665-704X
Sebenzile MyeniRocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Jean CelliPaul G. Allen School for Global Health, Washington State University, Pullman, Washington, USA.ORCID 0000-0002-6793-1788
Washington State University · USNational Institutes of Health · USUniversity of Vermont · US

Funding

TRAINING IN BIOTECHNOLOGY: EMPHASIS ON PROTEIN CHEMISTRYT32GM008336 · NIGMS · WASHINGTON STATE UNIVERSITY · PI CALL, DOUGLAS R. · 1989 to 2023
$8.9M
Infectious Diseases and Microbial Immunology Training ProgramT32AI007025 · NIAID · WASHINGTON STATE UNIVERSITY · PI Thomas H KAWULA, M KARIUKI NJENGA · 1985 to 2026
$7.4M
Remodeling of intracellular membrane traffic by Brucella effectorsR01AI158372 · NIAID · WASHINGTON STATE UNIVERSITY · PI JEAN A CELLI · 2022 to 2026
$3.0M
Effectors of Brucella intracellular replicationR01AI129992 · NIAID · WASHINGTON STATE UNIVERSITY · PI CELLI, JEAN A · 2017 to 2021
$2.1M
ER-associated degradation (ERAD) in the Brucella intracellular cycleR21AI127830 · NIAID · WASHINGTON STATE UNIVERSITY · PI CELLI, JEAN A · 2017 to 2018
$420k
NIAID NIH HHS R01 AI129992NIAID NIH HHS R01 AI158372NIAID NIH HHS R21 AI127830NIAID NIH HHS T32 AI007025NIGMS NIH HHS T32 GM008336
6 · The paper itself

Abstract

Brucella abortus, the intracellular causative agent of brucellosis, relies on type IV secretion system (T4SS) effector-mediated modulation of host cell functions to establish a replicative niche, the Brucella-containing vacuole (BCV). Brucella exploits the host's endocytic, secretory, and autophagic pathways to modulate the nature and function of its vacuole from an endocytic BCV (eBCV) to an endoplasmic reticulum (ER)-derived replicative BCV (rBCV) to an autophagic egress BCV (aBCV). A role for the host ER-associated degradation pathway (ERAD) in the B. abortus intracellular cycle was recently uncovered, as it is enhanced by the T4SS effector BspL to control the timing of aBCV-mediated egress. Here, we show that the T4SS effector BspA also interferes with ERAD, yet to promote B. abortus intracellular proliferation. BspA was required for B. abortus replication in bone marrow-derived macrophages and interacts with membrane-associated RING-CH-type finger 6 (MARCH6), a host E3 ubiquitin ligase involved in ERAD. Pharmacological inhibition of ERAD and small interfering RNA (siRNA) depletion of MARCH6 did not affect the replication of wild-type B. abortus but rescued the replication defect of a

Indexed as

Bacterial ProteinsBrucella abortusBrucellosisMembrane ProteinsType IV Secretion SystemsAnimalsBlood ProteinsEndoplasmic ReticulumEndoplasmic Reticulum-Associated DegradationMacrophagesMiceMice, Inbred C57BLUbiquitin-Protein LigasesBacterial ProteinsBlood ProteinsBspA protein, bacteriaMARCH6 protein, mouseMembrane ProteinsType IV Secretion SystemsUbiquitin-Protein LigasesUBXD8 protein, mouseBrucellaBspAendoplasmic reticulumERADMARCH6type IV secretion

Identifiers

PMID37129527
PMCPMC10187129
OpenAlexW4367321653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.